Back to HALO
Boston Trust Walden Corp → HALO
Boston Trust Walden Corp HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$46.3M
Q3 2026
Peak value
$68.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $32.9M |
| Q4 2025 | $19.7M |
| Q1 2026 | $26.6M |
| Q1 2026 | $17.3M |
| Q2 2026 | $49.9M |
| Q2 2026 | $34.8M |
| Q3 2026 | $68.1M |
| Q3 2026 | $46.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $46.3M | 419.2K | — | — |
| Q3 2026 | $68.1M | 616.6K | — | — |
| Q2 2026 | $34.8M | 445.2K | — | — |
| Q2 2026 | $49.9M | 637.8K | — | — |
| Q1 2026 | $17.3M | 268.1K | — | — |
| Q1 2026 | $26.6M | 411.5K | — | — |
| Q4 2025 | $19.7M | 292.8K | — | — |
| Q4 2025 | $32.9M | 489.1K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M